Gilead Sciences
GILD
GILD
1,708 hedge funds and large institutions have $75.9B invested in Gilead Sciences in 2024 Q1 according to their latest regulatory filings, with 138 funds opening new positions, 633 increasing their positions, 727 reducing their positions, and 169 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
13% less repeat investments, than reductions
Existing positions increased: 633 | Existing positions reduced: 727
18% less first-time investments, than exits
New positions opened: 138 | Existing positions closed: 169
39% less funds holding in top 10
Funds holding in top 10: 23 → 14 (-9)
Holders
1,708
Holding in Top 10
14
Calls
$728M
Puts
$684M
Top Buyers
| 1 | +$360M | |
| 2 | +$286M | |
| 3 | +$257M | |
| 4 |
Two Sigma Investments
New York
|
+$233M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$213M |
Top Sellers
| 1 | -$1.29B | |
| 2 | -$771M | |
| 3 | -$337M | |
| 4 |
Goldman Sachs
New York
|
-$326M |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$257M |